Short-term, self-regulating therapies may help alleviate long COVID symptoms

A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies.

40 doesn’t look good on Hatch-Waxman

As the Hatch-Waxman Act approaches its 40th anniversary, it’s time to critically examine its legacy and what it actually gave us: the highest drug prices in

September 23, 2024

FDA accepts Sentynl’s CUTX-101 NDA for priority review

CUTX-101 is intended to treat Menkes disease. Credit: luchschenF / Shutterstock. The US Food and Drug Administration (FDA) has accepted for filing and priority review

January 7, 2025

Long-term exercise leads to healthier fat storage in obese individuals

People with obesity who are long-time exercisers have healthier belly fat tissue and can store fat there more effectively than nonexercisers with obesity, according to

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.